Coronavirus live news: vaccine acceptance rising in UK, US and France; South Africa eases restrictions

and local public health authorities will use Food and Drug Administration (FDA) and CDC guidance as they administer the first 3.9m doses, which will be shipped through distribution partner McKesson Corp. 1.43am GMT New Zealand’s prime minister, Jacinda Ardern, has expressed frustration over rule-breaking by people implicated in the recent cluster of coronavirus cases, leading to further restrictions for Auckland.The city re-entered lockdown with level-three restrictions in place for at least a week from Sunday following the discovery of a community case of unknown origin.
believe today’s recommendation from the CDC to begin use of our vaccine as part of the US national immunization program will add a critical tool in the fight against Covid,” Paul Stoffels, J&J’s chief scientific officer, said in a statement.“We’re
getting these doses out the door as soon as they’re available to ensure vaccines get into arms as quickly as possible,” one senior US official told reporters late on Sunday, adding that initial deliveries were expected by Tuesday.State
There was one abstention due to prior conflicts of interest.“We
Covid vaccine acceptance also rising in Japan, Germany and Sweden; South Africa lowers alert level; cases of Brazil variant found in UKCovid has connected UK communities and spurred volunteeringNHS hospital bosses urge ministers to increase ICU beds in EnglandAlarm over delays in border measures as Brazil Covid variant hits UKTop UK universities ‘use secret waiting lists’ due to Covid uncertaintySee all our coronavirus coverage 2.16am GMT A US Centers for Disease Control and Prevention advisory panel voted unanimously on Sunday to recommend Johnson & Johnson’s Covid shot for widespread use, and US officials said initial shipments would start on Sunday, Reuters reports.Providing a final clearance for the vaccine a day after it was authorised by US regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older.
Source: the guardian

Summary automatically generated by NewSUM A.I. from the following sources:

About the author